BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 11313811)

  • 21. TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression.
    Sung RS; Qin L; Bromberg JS
    Mol Ther; 2001 May; 3(5 Pt 1):757-67. PubMed ID: 11356080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer.
    Jacobs F; Snoeys J; Feng Y; Van Craeyveld E; Lievens J; Armentano D; Cheng SH; De Geest B
    Gene Ther; 2008 Apr; 15(8):594-603. PubMed ID: 18288213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk and prevention of anti-factor IX formation in AAV-mediated gene transfer in the context of a large deletion of F9.
    Fields PA; Arruda VR; Armstrong E; Chu K; Mingozzi F; Hagstrom JN; Herzog RW; High KA
    Mol Ther; 2001 Sep; 4(3):201-10. PubMed ID: 11545610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repeated administration of adenovector in the eye results in efficient gene delivery.
    Hamilton MM; Brough DE; McVey D; Bruder JT; King CR; Wei LL
    Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):299-305. PubMed ID: 16384977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination.
    Bramson JL; Hitt M; Gauldie J; Graham FL
    Gene Ther; 1997 Oct; 4(10):1069-76. PubMed ID: 9415313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
    Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
    Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent hepatic expression of human apo A-I after transfer with a helper-virus independent adenoviral vector.
    Van Linthout S; Lusky M; Collen D; De Geest B
    Gene Ther; 2002 Nov; 9(22):1520-8. PubMed ID: 12407424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient blocking of both B7.1 (CD80) and B7.2 (CD86) in addition to CD40-CD40L interaction fully abrogates the immune response following systemic injection of adenovirus vector.
    Ziller C; Stoeckel F; Boon L; Haegel-Kronenberger H
    Gene Ther; 2002 May; 9(9):537-46. PubMed ID: 11973629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Defining strategies to extend duration of gene expression from targeted compacted DNA vectors.
    Ziady AG; Kim J; Colla J; Davis PB
    Gene Ther; 2004 Sep; 11(18):1378-90. PubMed ID: 15269710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent delivery of GM-CSF and B7-1 using an oncolytic adenovirus elicits potent antitumor effect.
    Choi KJ; Kim JH; Lee YS; Kim J; Suh BS; Kim H; Cho S; Sohn JH; Kim GE; Yun CO
    Gene Ther; 2006 Jul; 13(13):1010-20. PubMed ID: 16525479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs.
    Fang B; Wang H; Gordon G; Bellinger DA; Read MS; Brinkhous KM; Woo SL; Eisensmith RC
    Gene Ther; 1996 Mar; 3(3):217-22. PubMed ID: 8646552
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity.
    Roberts DM; Nanda A; Havenga MJ; Abbink P; Lynch DM; Ewald BA; Liu J; Thorner AR; Swanson PE; Gorgone DA; Lifton MA; Lemckert AA; Holterman L; Chen B; Dilraj A; Carville A; Mansfield KG; Goudsmit J; Barouch DH
    Nature; 2006 May; 441(7090):239-43. PubMed ID: 16625206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer].
    Yang Q; Yang G; Wei L; Jia F; Wu M; Guo Y
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):775-9. PubMed ID: 12126551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intraocular adenoviral vector-mediated gene transfer in proliferative retinopathies.
    Mori K; Gehlbach P; Ando A; Wahlin K; Gunther V; McVey D; Wei L; Campochiaro PA
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1610-5. PubMed ID: 11980881
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenovirus vector-mediated overexpression of a truncated form of the p65 nuclear factor kappa B cDNA in dendritic cells enhances their function resulting in immune-mediated suppression of preexisting murine tumors.
    Lee JM; Mahtabifard A; Yamada R; Crystal RG; Korst RJ
    Clin Cancer Res; 2002 Nov; 8(11):3561-9. PubMed ID: 12429647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adenoviral vector expressing ICP47 inhibits adenovirus-specific cytotoxic T lymphocytes in nonhuman primates.
    Scaria A; Sullivan JA; St George JA; Kaplan JM; Lukason MJ; Morris JE; Plog M; Nicolette C; Gregory RJ; Wadsworth SC
    Mol Ther; 2000 Nov; 2(5):505-14. PubMed ID: 11082324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
    Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reexpression following readministration of an adenoviral vector in adult mice after initial in utero adenoviral administration.
    Lipshutz GS; Flebbe-Rehwaldt L; Gaensler KM
    Mol Ther; 2000 Oct; 2(4):374-80. PubMed ID: 11020353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of IL-6 in the inflammatory and humoral response to adenoviral vectors.
    Benihoud K; Salone B; Esselin S; Opolon P; Poli V; Di Giovine M; Perricaudet M; Saggio I
    J Gene Med; 2000; 2(3):194-203. PubMed ID: 10894265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strain related variations in adenovirally mediated transgene expression from mouse hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains.
    Barr D; Tubb J; Ferguson D; Scaria A; Lieber A; Wilson C; Perkins J; Kay MA
    Gene Ther; 1995 Mar; 2(2):151-5. PubMed ID: 7719932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.